Anika Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 61 U.S.-traded ETFs. ANIK has around 2.5M shares in the U.S. ETF market. The largest ETF holder of ANIK is the iShares Core S&P Small-Cap ETF (IJR), with approximately 890.92K shares. Investors may also find of interest that the ETF with the largest allocation to ANIK stock is Invesco S&P SmallCap Health Care ETF (PSCH), with a portfolio weight of 0.64%. On average, U.S. ETFs allocate 0.12% of ANIK to their portfolios.
Additionally, ANIK is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ANIK as a holding is the SPDR S&P Biotech ETF (XBI), with a return of 27.47%.